Lake Street analyst Mark Argento reiterated a Buy rating on Trupanion (TRUP – Research Report) today and set a price target of $50.00. The company’s shares closed last Friday at $29.36.
According to TipRanks, Argento is a 4-star analyst with an average return of 13.1% and a 42.66% success rate.
Currently, the analyst consensus on Trupanion is a Moderate Buy with an average price target of $36.83.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $69.15 and a one-year low of $18.45. Currently, Trupanion has an average volume of 669.2K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Trupanion (TRUP) Company Description:
Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment involves in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members and contracts include multiple pets. The company was founded by Darryl Rawlings in January 2000 and is headquartered in Seattle, WA.
Read More on TRUP:
- Aflac and Trupanion Comment on Renewed S-3 Registration Statement Filed in Accordance with 2020 Shareholder Agreement
- Trupanion files to sell 3.64M shares of common stock for holders
- Global Veterinary Authorities Delve into Trupanion Data, Gaining Insight into Current Canine Respiratory Illness Concerns
- Supporting Your Pet’s Behavioral Health During the Back-to-Office Transition: Join Trupanion’s YouTube Premiere for Expert Guidance
- Trupanion’s Holiday Safety Guide: Protecting Your Pets During Festive Seasons
